TCF7L2
From SNPedia
| is a | gene |
| is | mentioned by |
| wikipedia | TCF7L2 |
| TCF7L2 | |
| gopubmed | TCF7L2 |
| 23andMe | TCF7L2 |
dbSNP 6934
PubMed 6934
SADR 6934
HugeNav 6934
HEFalMp TCF7L2
| Chromosome position | Summary | |
|---|---|---|
| Rs11196205 | 114797037114,797,037 | |
| Rs12255372 | 114798892114,798,892 | |
| Rs3814570 | 114698499114,698,499 | |
| Rs4506565 | 114746031114,746,031 | |
| Rs7901695 | 114744078114,744,078 | |
| Rs7903146 | 114748339114,748,339 |
These two snps rs12255372 and rs7903146 greatly influence your risk of Type-2 diabetes.
This has been confirmed by
- several researchers ([PMID 16936217] [PMID 16855264] [1] [PMID 16936217])
- Research [[2] [PMID 16936217] shows snps in the gene TCF7L2 significantly increases the risk of Type-2 diabetes.
- Refining the impact of TCF7L2 gene variants on Type-2 diabetes and adaptive evolution [PMID 17206141].
- [3] Carrying two copies of a common variant of TCF7L2 doubles your chances of developing Type-2 diabetes and puts you in a similar risk category to being clinically obese. A common variant of the gene increased the risk of developing diabetes by 50 per cent. Carrying two copies of the variant gene increased the risk two-fold, to nearly 100 per cent. In the population as a whole, the impact of this gene on the risk of developing diabetes is as big as the problem of being clinically obese (having a body mass index over 30).
- Polymorphism in TCF7L2 is associated with reduced insulin secretion in nondiabetic women [PMID 17130514]
This news article summarizes how snps increase the risk
IHOP Information Hyperlinked Over Proteins.
[PMID 17519421] Variation in TCF7L2 influences therapeutic response to sulfonylureas - related to diabetes